← Leaderboards
W K Alfred Yung
University Of Texas Md Anderson Can Ctr
$11,446,069
Attributed
$16,607,947
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2005–17$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$27,992,947 · 10
By mechanism
P50$14,513,067 · 4
U24$7,742,817 · 1
R01$5,176,572 · 3
U01$418,981 · 1
P01$141,510 · 1
Top collaborators
- Gordon B. Mills6 shared
- John N Weinstein6 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Xifeng Wu$28,679,533
- Amr Soliman$8,984,631
- Margaret R Spitz$17,223,484
- Elizabeth L Travis$5,557,622
- Gabriel Lopez-Berestein$9,617,602
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaBaseClinical TrialsTumorMolecularProgramsTumor Suppressor GenesAngiogenesisDesignFundingSignal TransductionMalignant Neoplasm Of BrainGlioblastomaLeadCellsCombined Modality TherapyPathway InteractionsMolecular ProfilingInhibitor/AntagonistResearch PersonnelSignal PathwayVascular Endothelial Growth FactorsIn VivoGrowth Factor
Grant awards (51)
Targeting the PI3K Pathway in Malignant Glioma$242,477
P50 · FY2017 · CA · contact PI
Targeting the PI3K Pathway in Malignant Glioma$228,190
P50 · FY2016 · CA · contact PI
Targeting the PI3K Pathway in Malignant Glioma$232,984
P50 · FY2015 · CA · contact PI
Targeting the PI3K Pathway in Malignant Glioma$222,389
P50 · FY2014 · CA · contact PI
Targeting the PI3K Pathway in Malignant Glioma$225,167
P50 · FY2013 · CA · contact PI
SPORE in Brain Cancer$2,300,000
P50 · FY2012 · CA · contact PI
Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)$1,587,106
U24 · FY2012 · CA
Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination$279,127
P50 · FY2012 · CA · contact PI
Career Development Program$144,227
P50 · FY2012 · CA · contact PI
SPORE in Brain Cancer$2,185,000
P50 · FY2011 · CA · contact PI
Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)$1,438,358
U24 · FY2011 · CA
Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination$277,056
P50 · FY2011 · CA · contact PI
Career Development Program$142,914
P50 · FY2011 · CA · contact PI
SPORE in Brain Cancer$2,300,000
P50 · FY2010 · CA · contact PI
Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)$1,491,837
U24 · FY2010 · CA
Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)$900,000
U24 · FY2010 · CA
Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)$841,344
U24 · FY2010 · CA
Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination$279,180
P50 · FY2010 · CA · contact PI
Deciphering synergistic combinatorial targets in glioma$265,423
R01 · FY2010 · CA · contact PI
Career Development Program$143,764
P50 · FY2010 · CA · contact PI
SPORE in Brain Cancer$2,300,000
P50 · FY2009 · CA · contact PI
Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)$1,484,172
U24 · FY2009 · CA
Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination$278,463
P50 · FY2009 · CA · contact PI
Deciphering synergistic combinatorial targets in glioma$265,423
R01 · FY2009 · CA · contact PI
Career Development Program$143,139
P50 · FY2009 · CA · contact PI
SPORE in Brain Cancer$2,300,000
P50 · FY2008 · CA · contact PI
Deciphering synergistic combinatorial targets in glioma$265,423
R01 · FY2008 · CA · contact PI
Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination$190,893
P50 · FY2008 · CA · contact PI
Career Development Program$98,097
P50 · FY2008 · CA · contact PI
Analysis of a 10Q Tumor Suppressor Gene$286,350
R01 · FY2007 · CA · contact PI
Deciphering synergistic combinatorial targets in glioma$265,423
R01 · FY2007 · CA · contact PI
Triple Anti-Angiogenic Therapy for Brain Tumors$190,620
R01 · FY2007 · CA · contact PI
Analysis of a 10Q Tumor Suppressor Gene$294,903
R01 · FY2006 · CA · contact PI
Deciphering synergistic combinatorial targets in glioma$273,350
R01 · FY2006 · CA · contact PI
Triple Anti-Angiogenic Therapy for Brain Tumors$196,313
R01 · FY2006 · CA · contact PI
Analysis of a 10Q Tumor Suppressor Gene$302,000
R01 · FY2005 · CA
Triple Anti-Angiogenic Therapy for Brain Tumors$251,038
R01 · FY2005 · CA
Analysis of a 10Q Tumor Suppressor Gene$302,000
R01 · FY2004 · CA
Triple Anti-Angiogenic Therapy for Brain Tumors$251,038
R01 · FY2004 · CA
Analysis of a 10Q Tumor Suppressor Gene$302,000
R01 · FY2003 · CA
NABTC--CLINICAL CENTER$111,084
U01 · FY2003 · CA
10Q TUMOR SUPPRESSOR GENE$293,026
R01 · FY2002 · CA
TRIPLE ANTI ANGIOGENIC THERAPY FOR BRIAN TUMORS$203,850
R01 · FY2002 · CA
NABTC--CLINICAL CENTER$104,477
U01 · FY2002 · CA
10Q TUMOR SUPPRESSOR GENE$284,490
R01 · FY2001 · CA
TRIPLE ANTI ANGIOGENIC THERAPY FOR BRIAN TUMORS$203,850
R01 · FY2001 · CA
NABTC--CLINICAL CENTER$100,440
U01 · FY2001 · CA
10Q TUMOR SUPPRESSOR GENE$276,202
R01 · FY2000 · CA
TRIPLE ANTI ANGIOGENIC THERAPY FOR BRIAN TUMORS$203,850
R01 · FY2000 · CA
MOLECULAR REGULATION OF ANGIOGENIC PHENOTYPE$141,510
P01 · FY2000 · CA
NABTC--CLINICAL CENTER$102,980
U01 · FY2000 · CA